CoChat
Sign Up
Cited by 22Bacterial Infections and VaccinesPneumonia and Respiratory InfectionsMicrobial infections and disease research

The DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.

Epidemiology of bacterial meningitis in the North American Arctic, 2000–2010

Open access
Gounder, Prabhu P., Zulz, Tammy, Desai, Shalini, Stenz, Flemming, Rudolph, Karen, Tsang, Raymond, Tyrrell, Gregory J., Bruce, Michael G.·2015·Journal of Infection
DOI 10.1016/j.jinf.2015.04.001PMC PMC4560175
Open this paper in CoChat — free account

Abstract

Objective To determine the incidence of meningitis caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in the North American Arctic during 2000-2010.Methods Surveillance data were obtained from the International Circumpolar Surveillance network. We defined a case of bacterial meningitis caused by H. influenzae, N. meningitidis, or S. pneumoniae as a culture-positive isolate obtained from a normally sterile site in a resident with a meningitis diagnosis.Results The annual incidence/100,000 persons for meningitis caused by H. influenzae, N. meningitidis, and S. pneumoniae among all North American Arctic residents was: 0.6, 0.5, and 1.5, respectively; the meningitis incidence among indigenous persons in Alaska and Canada (indigenous status not recorded in Greenland) for those three bacteria was: 2.1, 0.8, and 2.4, respectively. The percentage of pneumococcal isolates belonging to a 7-valent pneumococcal conjugate vaccine serotype declined from 2000-2004 to 2005-2010 (31%-2%, p-value <0.01). During 2005-2010, serotype a caused 55% of H. influenzae meningitis and serogroup B caused 86% of meningococcal meningitis.Conclusions Compared with all North American Arctic residents, indigenous people suffer disproportionately from bacterial meningitis. Arctic residents could benefit from the development of an H. influenzae serotype a vaccine and implementation of a meningococcal serogroup B vaccine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jinf.2015.04.001

Cites

25 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Additional meta-analyses of two studies conducted in Northern America demonstrated that S. pneumoniae was the most common pathogen causing bacterial meningitis in 'all ages', with a weighted mean of 43.1%.

    “Additional meta-analyses of two studies conducted in Northern America demonstrated that S. pneumoniae was the most common pathogen that caused bacterial meningitis in ‘all ages’, with a weighted mean of 43.1% (S5 Table; [55, 56]).”

    From Global etiology of bacterial meningitis: A systematic review and meta-analysis. (2018) · cites this paper as [56]

    The Results (Descriptive Epidemiology; page not provided) report 139 pneumococcal cases among 247 cases in the North American Arctic, more than for either of the other two organisms studied. This supports the paper as one study contributing to the citing authors’ comparison, but it does not report the two-study meta-analysis or its 43.1% weighted mean. Its finding is also limited to three bacterial pathogens in the Arctic, not all causes across Northern America. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

  • S. pneumoniae remains an important cause of bacterial meningitis in regions with high vaccine coverage such as Northern America.

    “and it remains an important cause of bacterial meningitis in regions with high vaccine coverage such as Northern America. [55, 56]”

    From Global etiology of bacterial meningitis: A systematic review and meta-analysis. (2018) · cites this paper as [56]

    The Discussion (page not provided) identifies S. pneumoniae as the leading cause of meningitis in the study’s North American Arctic population. The paper does not establish that this population had high pneumococcal vaccine coverage; it instead anticipates a further decline in meningitis with increased coverage. Its finding also concerns the North American Arctic, not Northern America generally. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

2 of the 28 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Metadata

Authors
Gounder, P. P., Zulz, T., Desai, S., Stenz, F., Rudolph, K., Tsang, R., Tyrrell, G. J., & Bruce, M. G.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Public Health Agency of Canada (CA)
  • Greenland Government (GL)
Corresponding author
Gounder, Prabhu P.
ORCID
Venue
Journal of Infection
Publisher
Elsevier BV
Published
2015-08
Volume
71
Issue
2
Pages
179-187
ISSN
0163-4453 (ISSN-L)
DOI
10.1016/j.jinf.2015.04.001
PMC
PMC4560175
OpenAlex
W2043891129
Semantic Scholar
0225eb19bbcdbb3edf840f9d2b2262d6883b20ac
Cited by
22
References
28
Citations by year
2025: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 1
FWCI
3.28
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Infection (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (CC999999)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
Keywords
bacterial meningitis, Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, incidence, North American Arctic, indigenous peoples, Alaska, Canada, pneumococcal serotypes, serotype A, serogroup B, 7-valent pneumococcal conjugate vaccine, meningococcal B vaccine
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Arctic Regions, Child, Child, Preschool, Female, Haemophilus influenzae, Humans, Infant, Infant, Newborn, Male, Middle Aged, Neisseria meningitidis, North America, Streptococcus pneumoniae, Incidence, Meningitis, Bacterial, Young Adult, Epidemiological Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review